Madrigal Pharmaceuticals (NASDAQ:MDGL) advanced 9.4% after a report that potential sale talks may have advanced. Madrigal ...
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...
The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
Attorney General Todd Rokita has filed a lawsuit alleging that Mylan and Pfizer have conspired to increase EpiPen’s price by ...
Insider Monkey on MSN4h
Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside PotentialWe recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.
The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...
For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...
Indiana Attorney General Todd Rokita is suing two pharmaceutical companies over alleged anticompetitive acts regarding a life ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
The pharmaceutical industry operates within one of the most highly regulated environments globally, where precision, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results